Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 16/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 15/20 | 0.35 |
| ▸ | PGR | P06401 | 12/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5777927 | 0.84 | NR3C1 (0.48) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL4154304 | 0.79 | PTGS1 (0.38) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL5779030 | 0.78 | PTGS1 (0.37) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL4467721 | 0.78 | NR3C1 (0.47) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL5779024 | 0.77 | PTGS1 (0.32) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL4167063 | 0.75 | NR3C1 (0.33) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL6226890 | 0.73 | PTGS1 (0.37) | NR3C1NR3C2PGRPTGS1PTGS2 | |
| SCHEMBL13754638 | 0.71 | NR3C1 (0.31) | NR3C1NR3C2PGR | |
| SCHEMBL4489826 | 0.70 | NR3C1 (0.30) | NR3C1NR3C2PGR | |
| SCHEMBL14146333 | 0.68 | NR3C1 (0.45) | NR3C1NR3C2PGRPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673088-A1 | 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO¬2,3-C|PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005030213-A1 | 1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-04-07 | — | — | WO | disclosed |